Becker's Healthcare August 13, 2024
Elizabeth Gregerson

CMS will share its first round of negotiated Medicare drug costs on Sept. 1, though two drugmakers are still fighting the negotiations.

Here are 10 things to know about the upcoming announcement:

  1. The Inflation Reduction Act was signed into law in August 2022, giving Medicare the authority to negotiate with drug companies over the price of certain drugs.
  2. On Aug. 29, CMS announced the list of 10 Medicare Part D drugs that were selected for price negotiations.
  3. Drugs on the list treat heart conditions, blood clots, leukemia/lymphoma, diabetes, rheumatoid arthritis and psoriasis.
  4. The 10 drugs are: Eliquis, Enbrel, Farxiga, Fiasp/NovoLog, Entresto, Imbruvica, Januvia, Jardiance, Stelara and Xarelto.
  5. The drugmakers involved in negotiations are: Bristol Myers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Related Articles:
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings
What Medicare Negotiation Tells Us About Drug Pricing In The U.S.
A Core Measure Set For Age-Friendly Health Care Delivery
KFF Health Tracking Poll September 2024: Support for Reducing Prescription Drug Prices Remains High, Even As Awareness of IRA Provisions Lags
Physicians vs. reimbursements: 3 updates

Share This Article